| Valentina Moirangthem, MD | |
|
1650 Selwyn Ave, Bronx, NY 10457-7626 | |
| (718) 239-8359 | |
| (718) 579-3901 |
| Full Name | Valentina Moirangthem |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 24 Years |
| Location | 1650 Selwyn Ave, Bronx, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548400856 | NPI | - | NPPES |
| MD14676 | Other | RI | RI STATE LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bronx Health System | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bronxcare Health System | 3870404429 | 270 |
News Archive
There is nothing better on a hot, summer day than a refreshing dip in a community pool, water park, lake or ocean. However, bacteria and parasites can lurk in all kinds of water and put a real damper on summertime fun unless people practice a few, simple safety tips.
A new study published in Public Health Nutrition examines the potential effects of Brexit on the 'Sugar Tax' and coronary heart disease in England.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
Cardiac allograft vasculopathy (CAV), also known as chronicle rejection, is a leading cause of graft (foreign heart) loss and death in patients who survive the first year after heart transplantation. The typical pathological change of CAV is gradually thickening of coronary wall in "foreign" heart due to continuous immunological reaction between donated heart and the host. In some cases, undetected CAV may silently cause graft failure with global myocardial ischemia without any documented infarction signs. Thus, continually monitoring development of asymptomatic CAV is important for selecting prophylactic strategies to get better prognosis. However, most current examinations of detecting CAV are invasive and with certain risks.
› Verified 9 days ago
| Entity Name | Bronxcare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245390855 PECOS PAC ID: 3870404429 Enrollment ID: O20040526001082 |
News Archive
There is nothing better on a hot, summer day than a refreshing dip in a community pool, water park, lake or ocean. However, bacteria and parasites can lurk in all kinds of water and put a real damper on summertime fun unless people practice a few, simple safety tips.
A new study published in Public Health Nutrition examines the potential effects of Brexit on the 'Sugar Tax' and coronary heart disease in England.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
Cardiac allograft vasculopathy (CAV), also known as chronicle rejection, is a leading cause of graft (foreign heart) loss and death in patients who survive the first year after heart transplantation. The typical pathological change of CAV is gradually thickening of coronary wall in "foreign" heart due to continuous immunological reaction between donated heart and the host. In some cases, undetected CAV may silently cause graft failure with global myocardial ischemia without any documented infarction signs. Thus, continually monitoring development of asymptomatic CAV is important for selecting prophylactic strategies to get better prognosis. However, most current examinations of detecting CAV are invasive and with certain risks.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Valentina Moirangthem, MD 1650 Selwyn Ave, Bronx, NY 10457-7626 Ph: (718) 239-8359 | Valentina Moirangthem, MD 1650 Selwyn Ave, Bronx, NY 10457-7626 Ph: (718) 239-8359 |
News Archive
There is nothing better on a hot, summer day than a refreshing dip in a community pool, water park, lake or ocean. However, bacteria and parasites can lurk in all kinds of water and put a real damper on summertime fun unless people practice a few, simple safety tips.
A new study published in Public Health Nutrition examines the potential effects of Brexit on the 'Sugar Tax' and coronary heart disease in England.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
Cardiac allograft vasculopathy (CAV), also known as chronicle rejection, is a leading cause of graft (foreign heart) loss and death in patients who survive the first year after heart transplantation. The typical pathological change of CAV is gradually thickening of coronary wall in "foreign" heart due to continuous immunological reaction between donated heart and the host. In some cases, undetected CAV may silently cause graft failure with global myocardial ischemia without any documented infarction signs. Thus, continually monitoring development of asymptomatic CAV is important for selecting prophylactic strategies to get better prognosis. However, most current examinations of detecting CAV are invasive and with certain risks.
› Verified 9 days ago
Selina Sultana Zaman, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 718-920-9000 | |
Dr. Jyothi B Kudakandira, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-960-1234 | |
Mana Rao, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Dr. Keshav Teelucksingh, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Tannaz Iranpour Boroujeni, M.D Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 617-840-0110 | |
Heather Root, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-8592 Fax: 718-405-0610 | |
Benjamin Tuttle Hayes, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 305 E 161st St, Bronx, NY 10451 Phone: 718-579-2500 Fax: 718-579-2599 |